Peripartum cardiomyopathy (PPCM) is a rare form of congestive heart failure that affects women late in pregnancy or in the early puerperium. PPCM is a disorder of unknown etiology that can have potentially devastating consequences. Although the etiology of PPCM remains unclear, a number of risk factors for this disorder have been proposed. However, the disease can occurred in women without these risk factors. Preeclampsia is associated with PPCM. However, cardiomyopathy is an infrequent complication of preeclampsia. Treatment of PPCM is similar to that other types of congestive heart failure. The pregnancy outcome is uncertain. Probably it depends on whether ther heart size returns to normal. We present the case of a 38 years old woman, who developed in an 33rd week of gestation a PPCM. She had some risk factors (include preeclampsia) but had a favorable evolution with conventional treatment. The rarity of the syndrome, its potential consequences, and the probable association with preeclampsia, stimulated us to present this case.

Download full-text PDF

Source

Publication Analysis

Top Keywords

risk factors
12
peripartum cardiomyopathy
8
cardiomyopathy infrequent
8
congestive heart
8
heart failure
8
ppcm
6
[preeclampsia peripartum
4
infrequent association]
4
association] peripartum
4
cardiomyopathy ppcm
4

Similar Publications

Introduction: Metabolic and bariatric surgery (MBS) is increasingly used for obesity and metabolic disease, with safety profiles showing it is among the safest major operations. The last 20 + years have noted significantly improved safety that has been accompanied by decreasing length of stay and select populations electing for outpatient surgery, leading to continued decreases in cost. Regardless, readmissions and complications still occur, requiring inpatient postoperative care (IP-POC).

View Article and Find Full Text PDF

Pre-exposure prophylaxis (PrEP) has proven to be a powerful tool in preventing HIV infection. There is limited information about the factors associated with willingness to use different PrEP modalities among adolescent girls and young women (AGYW) in Africa. We assessed willingness to use long-acting injectable PrEP (LAI-PrEP) among 14-24-year-old AGYW at high risk of HIV in Uganda, and associated factors determined using multivariable complementary log-log regression.

View Article and Find Full Text PDF

This study aimed to explore the awareness, willingness, and engagement with pre-exposure prophylaxis (PrEP) among high-risk Chinese men who have sex with men (MSM) and to investigate the factors influencing its use. A cross-sectional survey of 1800 HIV-negative MSM was conducted in Chengdu, Suzhou, and Wuhan between June 2022 and February 2023 through in-person and online recruitment methods. Univariate and multivariate logistic regression analyses were used to identify predictors of PrEP use.

View Article and Find Full Text PDF

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.

Adv Biotechnol (Singap)

January 2025

National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

The co-circulation of influenza and SARS-CoV-2 has led to co-infection events, primarily affecting children and older adults, who are at higher risk for severe disease. Although co-infection prevalence is relatively low, it is associated with worse outcomes compared to mono-infections. Previous studies have shown that the outcomes of co-infection depend on multiple factors, including viral interference, virus-host interaction and host response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!